Asset Details
Do you wish to reserve the book?
Molecular Mechanisms of SGLT2 Inhibitor on Cardiorenal Protection
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Molecular Mechanisms of SGLT2 Inhibitor on Cardiorenal Protection
Do you wish to request the book?
Molecular Mechanisms of SGLT2 Inhibitor on Cardiorenal Protection
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Molecular Mechanisms of SGLT2 Inhibitor on Cardiorenal Protection
2020
Overview
The development of sodium-glucose transporter 2 inhibitor (SGLT2i) broadens the therapeutic strategies in treating diabetes mellitus. By inhibiting sodium and glucose reabsorption from the proximal tubules, the improvement in insulin resistance and natriuresis improved the cardiovascular mortality in diabetes mellitus (DM) patients. It has been known that SGLT2i also provided renoprotection by lowering the intraglomerular hypertension by modulating the pre- and post- glomerular vascular tone. The application of SGLT2i also provided metabolic and hemodynamic benefits in molecular aspects. The recent DAPA-CKD trial and EMPEROR-Reduced trial provided clinical evidence of renal and cardiac protection, even in non-DM patients. Therefore, the aim of the review is to clarify the hemodynamic and metabolic modulation of SGLT2i from the molecular mechanism.
Publisher
MDPI AG,MDPI
Subject
/ Animals
/ Anti-Inflammatory Agents, Non-Steroidal - pharmacology
/ Autonomic Nervous System Diseases - drug therapy
/ Autonomic Nervous System Diseases - physiopathology
/ Cardio-Renal Syndrome - drug therapy
/ Cardio-Renal Syndrome - physiopathology
/ Diabetes
/ Diabetes Mellitus - drug therapy
/ Diabetes Mellitus - physiopathology
/ Glucose
/ Humans
/ Ketosis - chemically induced
/ Kidney Glomerulus - physiopathology
/ Kidneys
/ Plasma
/ Review
/ Sodium
